Theme: AI-Enhanced Microbiology: Transforming diagnostics in the digital era
11 February 2026
WHX Labs Dubai
Clinical Microbiology
Overview
This conference track examines how industry consolidation in microbiology and infectious disease diagnostics is being accelerated through digital transformation and Next-Generation Sequencing (NGS) technologies, creating integrated approaches that enhance diagnostic accuracy for challenging infections like gram-negative bacteria and viral hepatitis. Participants will discover how consolidated laboratory systems and AI-powered platforms are revolutionizing antimicrobial susceptibility testing and rapid diagnostics, enabling unified workflows that streamline stewardship initiatives and provide cohesive treatment decision-making frameworks to effectively address the complex challenges of antimicrobial resistance.
Chairs
Dr Adnan Alatoom
Clinical Pathology and Microbiology Consultant,
Dubai Health, Dubai, UAE
Dr Rubina Lone
Consultant Pathologist,
Head Laboratory Medicine, Al Jalila Children’s Hospital and Latifa Hospital; Division Chief of Microbiology, Dubai Health
Key topics
❯ Consolidation in the microbiology lab
❯ Candida Auris
❯ Infections in immunocompromised hosts
❯ Best practices in antimicrobial susceptibility testing and reporting
❯ NGS in clinical microbiology
❯ Treatment of difficult Gram negative infections
❯ Updates in viral hepatitis
What’s New
❯ New co-chair
❯ CAP/ASCP/CLSI guidelines
❯ Public health, Infectious Diseases